Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL4P1 is a non-functional pseudogene derived from the gene encoding ribosomal protein L4, part of the large ribosomal 60S subunit[3]. The functional parent gene (RPL4) is crucial for ribosome assembly and protein synthesis, but RPL4P1 itself does not encode a functional protein and has no known biological roles, disease associations, or relevance as a drug target. Like many ribosomal protein genes, its processed pseudogenes are dispersed throughout the human genome and do not contribute to therapeutic or diagnostic applications[3].\n\nCritical distinction: It is important not to confuse RPL4P1 (pseudogene) with ribosomal protein L4 (RPL4), which is a bona fide ribosomal protein involved in ribosome structure and function, with established roles in ribosome assembly and feedback regulation of protein synthesis[1][2][3]. RPL4 is not a therapeutic target, but is relevant for studies of protein synthesis; RPL4P1 itself has no protein product or known function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ribosomal protein L4 pseudogene 1 (RPL4P1).